Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

70 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details
Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

NCT03232593

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +27 more
Locations
  • Dongnam Inst.of Radiological & Medical Sciences Busan, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Inje university Haeundae Paik Hospital Busan, South Korea
  • Dong-A University Hospital Busan, South Korea
View all 56 locations
View Trial Details
Completed

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

NCT01286987

Conditions
Adnexal Diseases, Advanced or Recurrent Solid Tumors, Breast Diseases, +49 more
Locations
  • Scottsdale Healthcare Scottsdale, Arizona, United States
  • Virginia G. Piper Cancer Center Research Pharmacy Scottsdale, Arizona, United States
  • (IRB# 12-000131) Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 15 locations
View Trial Details

Related conditions